用于多发性硬化症患者剖宫产的舒更葡糖钠
Sugammadex for Cesarean in a Patient with Multiple Sclerosis.
作者信息
Yılmaz Resul, Uzun Sema Tuncer, Reisli Ruhiye
机构信息
Department of Anesthesiology and Reanimation, Necmettin Erbakan University Meram Faculty of Medicine, Konya, Turkey.
出版信息
Sisli Etfal Hastan Tip Bul. 2019 Jul 5;53(2):195-198. doi: 10.14744/SEMB.2017.07108. eCollection 2019.
The aim of the present study was to discuss the management of anesthesia in our case with multiple sclerosis (MS) and to present the effects of sugammadex administration. A 36-year-old pregnant patient with MS disease was followed up for 6 years. She was on steroid treatment. The patient had not suffered the entire pregnancy. In addition to performing routine monitoring, "train of four" (TOF) monitorization was used. General anesthesia was given using propofol and rocuronium. At the end of the operation, muscle relaxation was reversed using sugammadex in the patient with a low TOF score. The patient was discharged on postoperative day 3. The most reliable method should be preferred in patients with MS. In patients under general anesthesia, the muscle relaxant effect is prolonged, and sugammadex can be safely used.
本研究的目的是讨论我们这位多发性硬化症（MS）患者的麻醉管理，并介绍舒更葡糖钠给药的效果。一名患有MS疾病的36岁孕妇接受了6年的随访。她正在接受类固醇治疗。该患者整个孕期都未出现病情发作。除了进行常规监测外，还使用了“四个成串刺激”（TOF）监测。使用丙泊酚和罗库溴铵进行全身麻醉。手术结束时，对TOF评分较低的患者使用舒更葡糖钠逆转肌肉松弛。患者术后第3天出院。对于MS患者，应首选最可靠的方法。在全身麻醉的患者中，肌肉松弛作用会延长，舒更葡糖钠可以安全使用。
Zotero 插件